psychosis
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotic, BMJ Mental Health, cardiovascular disease, cardiovascular events, cohort study, Denmark, Editor Eimear Foley, electronic health records, external validation, health inequalities, lasso regression, logistic regression, machine learning, mixed methods, mortality gap, physical health, physical health inequalities, prediction, psychosis, registry data, risk factors, risk prediction, schizophrenia, Sweden, topical, xgboostPredicting cardiovascular disease in schizophrenia: does machine learning actually help?
On average, people with schizophrenia spectrum disorders die 15 to 20 years…
-
antipsychotic, BMJ Mental Health, cardiovascular disease, cardiovascular events, cohort study, Denmark, Editor Eimear Foley, electronic health records, external validation, health inequalities, lasso regression, logistic regression, machine learning, mixed methods, mortality gap, physical health, physical health inequalities, prediction, psychosis, registry data, risk factors, risk prediction, schizophrenia, Sweden, topical, xgboostPredicting cardiovascular disease in schizophrenia: does machine learning actually help?
On average, people with schizophrenia spectrum disorders die 15 to 20 years…
-
anhedonia, bipolar disorder, Brain, endophenotype, fMRI, monetary incentive delay task, negative symptoms, neuroscience, polygenic risk score, Psychiatry, psychosis, reward processing, schizophrenia, ventral striatumReward Activation Failed as Bipolar-Psychosis Endophenotype
A 244-person functional MRI study found no significant evidence that ventral striatum…
-
agranulocytosis, antipsychotics, clozapine, Drugs, early intervention, FDA REMS, Finnish registry, first episode psychosis, negative symptoms, Psychiatry, psychosis, relapse prevention, schizophrenia, treatment-resistant schizophreniaEarly Clozapine in Schizophrenia: 34% Lower Relapse Risk
Clozapine has been the most effective antipsychotic in schizophrenia for almost 40…
-
early psychosis, education and employment, first episode psychosis, functional recovery, individual placement and support, NEET, Psychiatry, Psychology, psychosis, psychosis recovery, schizophrenia, schizophrenia spectrum disorders, SEEearly trial, supported education, supported employment, therapy, vocational recoveryEarly Psychosis Vocational Recovery: 53.3% NEET in SEEearly Trial
A 2026 SEEearly baseline report found that 53.3% of 184 young people…
-
autoimmune psychiatry, Brain, CSF biomarkers, immunopsychiatry, multiple sclerosis, neuroinflammation, neuroscience, OCD, Psychiatry, psychosis, sCD27, soluble CD27, T-cell activationsCD27 Biomarker Flags Autoimmune Disease in Severe Psychiatric Disorders
A 2026 immunopsychiatry cohort study found that soluble CD27 (sCD27), a marker…

